Study of the Acute Effects of Triheptanoin in Heart Failure
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Patients with dilated cardiomyopathy who present for indwelling right heart catheterization
will be enrolled and randomized to either control or triheptanoin oil for five days.
Hemodynamics will be assess serially.